Upgrade to SI Premium - Free Trial

SIGY (SIGY)

0.04 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Latest Headlines

Oragenics signs letter of intent to license blood purification technology May 7, 2026 8:30 AM - StreetInsider Oragenics Signs Letter of Intent to License CardioDialysis™ Technology from Sigyn Therapeutics to Target TBI-Induced Systemic Inflammation May 7, 2026 8:30 AM - Globe NewsWire Sigyn Therapeutics Launches Initiative to Evaluate Emerging Medical Technologies in Former NFL Players at Risk of CTE April 2, 2026 8:00 AM - StreetInsider Scientific American Highlights Scientific Discovery That Supports the Potential Use of CardioDialysis(TM) to Treat Neuroinflammatory Diseases March 24, 2026 8:00 AM - StreetInsider Sigyn Therapeutics Issues Shareholder Update Regarding Potential Merger and Asset Sale Initiatives March 14, 2026 8:29 AM - StreetInsider Full Article List